AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KAUG 311 min read$ALGN

ALIGN TECHNOLOGY INC (ALGN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

ALIGN TECHNOLOGY INC (ALGN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Align Technology Zeno Group Madelyn Valente Sarah Karlson (909) 833-5839 (828) 551-4201 mvalente@aligntech.com sarah.karlson@zenogroup.com QUENTIN BLACKFORD TO JOIN ALIGN TECHNOLOGY BOARD OF DIRECTORS Andrea L. Saia to Retire After 13 Years of Service TEMPE, Ariz. & SAN JOSE, Cal

Original reporting
SEC EDGAR 8-K
Published Aug 31, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$ALGN
Neutral
high confidence
Mentioned
$ALGN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ALGNNeutralLow
01

Why it matters

The appointment adds expertise in digital health; the retirement is a routine succession. No immediate financial metrics disclosed.

02

Market read

Corporate governance update with modest relevance for investors monitoring board composition.

03

What to watch

Blackford's experience in digital health and cardiology may open cross‑industry collaborations.

Relevance 6/10Novelty 5/10Timing: effective immediately

Background

SEC Form 8‑K filing reporting director changes at Align Technology, a Nasdaq‑listed medical device company.

Company-level read

Ticker impact

$ALGNNeutralHigh confidence
Context

Align Technology announced the appointment of Quentin Blackford to its board and the retirement of director Andrea Saia, effective September 2026.

Expected impact

Minimal short-term price movement expected.

Evidence & confidence

Director appointments are routine corporate actions with limited market effect unless the appointee brings significant strategic shifts.

Market effects

Sector

May signal continued focus on digital dentistry and healthcare innovation.

Regional

Limited to U.S. healthcare device sector.

Global

Low global impact.

Counterpoint

What could challenge this read

Board changes could be a prelude to strategic pivots that the market undervalues.

Key entities

  • Person
    Quentin Blackford

    CEO of iRhythm Technologies, appointed to Align board.

  • Person
    Andrea Saia

    Long‑time director retiring from Align board.

Read at source← All news

Related articles

SEP 1
$ALGNLow

Align Tech adds Quentin Blackford to board

Align Technology (ALGN) added Quentin Blackford, CEO of iRhythm Technologies, to its board, expanding it to 11 members. Blackford brings healthcare and digital innovation experience. Director Andrea L. Saia will retire in September 2026, reducing the board to 10 members.

theglobeandmail.com1 min
AUG 27
$ALGNMed

Are Wall Street Analysts Bullish on Align Technology Stock?

Align Technology (ALGN), a medical device company, has underperformed the broader market and healthcare sector ETF over the past 52 weeks. Analysts expect its adjusted EPS to grow 10.9% YoY by 2026, with a consensus 'Moderate Buy' rating. The mean price target is $207.07, implying a 30.1% upside. Piper Sandler maintained a 'Buy' rating with a $235 target.

barchart.com2 min
AUG 12
$ALGNMed

Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology said a Jinan Intermediate People’s Court issued a first-instance ruling on Aug. 10, 2026 in a China patent case against Angel. The court found Angel’s MasterForce and ATreat systems infringe Align’s CN113693748B patent and ordered Angel to stop use, manufacturing, and sales, awarding RMB 10 million in damages. Angel can appeal to China’s Supreme People’s Court.

antaranews.com4 min
AUG 12
$ALGNMed

Align Technology, Inc.: Align Technology Prevails in China Patent Infringement Action Against Angelalign

Align Technology (Nasdaq: ALGN) said China’s Jinan Intermediate People’s Court ruled in its favor in a patent infringement case against Angelalign’s China subsidiaries. The court found Angel infringed Align’s CN113693748B patent tied to extraction-gap-closure technology, ordering a stop to use and sales in China and awarding RMB 10 million in damages. Angel can appeal.

finanznachrichten.de4 min
AUG 10
$DDDMed

3D Printing Financials: 3D Systems, Prodways, and Align Build on Positive Momentum - 3DPrint.com

3D Systems reported Q2 revenue of $94.6M, flat YoY, with healthcare up 6.8% and aerospace/defense and data center infrastructure each growing over 20%. Adjusted EBITDA loss narrowed to $0.8M. It expects Q3 revenue of $96M to $99M. Prodways posted Q2 revenue of €10.5M (+5% YoY) and plans a €20M buyback. Align Technology reported record Q2 revenue of just over $1.05B (+4.3%), with clear aligner revenue up 8.2% and 2026 revenue growth guidance of 3% to 4%.

3dprint.com6 min
AUG 8
$ALGNMedAI 9/10

Align Technology (ALGN) Q2 2026 Earnings Call Transcript

Align Technology (ALGN) reported Q2 2026 revenue of $1,056.2 million, up 4.3% y/y, driven by record Clear Aligner volumes and higher ASPs. Clear Aligner revenue rose 8.2% to $870.9 million on 691,785 cases. Systems and Services revenue fell 10.8% to $185.3 million. Q3 revenue guidance is $1.00 to $1.02 billion; full-year growth 3% to 4%.

aol.com7 min